Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor. (Q34329186)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Chiara F Magnani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Angel F. Lopez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Virna Marin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Irene Pizzitola

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Greta M P Giordano Attianese

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Elisabetta Cribioli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Francesca Maltese

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Stefania Galimberti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Andrea Biondi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Dominique Bonnet

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Ettore Biagi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

25 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

389-401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

Efficient discrimination between different densities of target antigen by tetracycline-regulatable T bodies

24 February 2020

cites work

1 reference

Chimeric T-cell receptors: new challenges for targeted immunotherapy in hematologic malignancies

21 January 2018

1 reference

New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future

21 January 2018

1 reference

Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs

21 January 2018

1 reference

The suicide gene therapy challenge: how to improve a successful gene therapy approach

21 January 2018

1 reference

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial

21 January 2018

1 reference

Chimeric antigen receptor-engineered T cells for immunotherapy of cancer

21 January 2018

1 reference

Suicide gene therapy to increase the safety of chimeric antigen receptor-redirected T lymphocytes

21 January 2018

1 reference

T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity.

21 January 2018

1 reference

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

Inducible apoptosis as a safety switch for adoptive cell therapy

21 January 2018

1 reference

New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells

21 January 2018

1 reference

21 January 2018

Acute myeloid leukaemia

1 reference

Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells

21 January 2018

1 reference

Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies

21 January 2018

1 reference

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

21 January 2018

1 reference

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells

21 January 2018

1 reference

Function and signal transduction mediated by the interleukin 3 receptor system in hematopoiesis

21 January 2018

1 reference

21 January 2018

1 reference

Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.

21 January 2018

1 reference

Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation

21 January 2018

1 reference

Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study

21 January 2018

1 reference

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

21 January 2018

1 reference

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

21 January 2018

1 reference

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

CARs on track in the clinic

21 January 2018

1 reference

IL-3 receptor expression, regulation and function in cells of the vasculature

21 January 2018

1 reference

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

Auger electron radioimmunotherapeutic agent specific for the CD123+/CD131- phenotype of the leukemia stem cell population

21 January 2018

1 reference

Expression of complement components, receptors and regulators by human dendritic cells.

21 January 2018

1 reference

Cytokine-induced NK-like T cells: from bench to bedside

21 January 2018

1 reference

Diphtheria toxin fused to variant interleukin-3 provides enhanced binding to the interleukin-3 receptor and more potent leukemia cell cytotoxicity

21 January 2018

1 reference

Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation

21 January 2018

1 reference

Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells

21 January 2018

1 reference

Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy.

21 January 2018

1 reference

Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors

21 January 2018

1 reference

Comparison of different suicide-gene strategies for the safety improvement of genetically manipulated T cells.

21 January 2018

1 reference

Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy.

21 January 2018

1 reference

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

21 January 2018

1 reference

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

21 January 2018

1 reference

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

21 January 2018

1 reference

Cytokine induced killer cells as promising immunotherapy for solid tumors

21 January 2018

1 reference

Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells

21 January 2018

1 reference

Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia

21 January 2018

1 reference

Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis.

21 January 2018

1 reference

Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interaction.

21 January 2018

1 reference

T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells

21 January 2018

1 reference

High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.

21 January 2018

1 reference

Cancer stem cells: lessons from leukemia.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23432359%20AND%20SRC:MED&resulttype=core&format=json